Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Osiris Therapeutics (Osteocel Biologics Business)

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer of stem cell preservation products. The company engages in the production and manufacture of bone matrix product that preserves the native stem cell population found in marrow rich bone and is offered for the repair, replacement or reconstruction of bone defects.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Medical Supplies
Other Industries
Biotechnology
Acquirer
Primary Office
  • 7015 Albert Einstein Drive
  • Columbia, MD 21046
  • United States

Osiris Therapeutics (Osteocel Biologics Business) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Osiris Therapeutics (Osteocel Biologics Business)‘s full profile, request access.

Request full access to PitchBook

Osiris Therapeutics (Osteocel Biologics Business) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Osiris Therapeutics (Osteocel Biologics Business)‘s full profile, request access.

Request full access to PitchBook